Skip to main content
SpringerLink
Log in
Book cover

Vaccine Protocols pp 1–16Cite as

Overview of Vaccines

  • Protocol

Part of the book series: Methods in Molecular Medicine™ ((MIMM,volume 4))

Abstract

Most vaccines are designed as a prophylactic measure, that is, to stimulate the immune response so that on subsequent exposure to the particular infectious agent, the extent of infection in the vaccinated individual is so low that disease does not occur. There is also increasing interest in designing vaccines that may be effective as a therapeutic measure. There are two contrasting types of infectious processes.

This is a preview of subscription content, log in via an institution.

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Cadoz, M., Strady, A., Meigner, B., Taylor, J., Tartaglia, J., Paoletti, E., and Plotkin, S. (1992) Immunization with canarypox virus expressing rabies glycoprotein. Lancet 339, 1429–1432.

    Article  PubMed  CAS  Google Scholar 

  2. Clark, H. F. and Offit, P. A. (1994) Rotavirus vaccines, in Vaccines, 2nd ed. (Plotkin, S. A. and Mortimer, E. A., eds.), Saunders, Philadelphia, pp. 809–822.

    Google Scholar 

  3. Maassab, H. F., Shaw, M. W., and Heilman, C. A. (1994) Live influenza virus vaccine, in Vaccines, 2nd ed. (Plotkin, S. A. and Mortimer, E. A., eds.), Saunders, Philadelphia, pp. 781–801

    Google Scholar 

  4. Levine, M. M. (1994) Typhoid fever vaccines, in Vaccines, 2nd ed. (Plotkin, S. A. and Mortimer, E. A., eds.), Saunders, Philadelphia, pp. 597–634.

    Google Scholar 

  5. Tartaglia, J., Perkus, M. E., and Taylor, J. (1992) NYVAC: a highly attenuated strain of vaccinia virus. Virology 188, 217–232.

    Article  PubMed  CAS  Google Scholar 

  6. Daniel, M. D, Kirchhoff, F., Czajak, S. C., Sehgal, P. K, and Desrosiers, R. C. (1992) Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938–1940.

    Article  PubMed  CAS  Google Scholar 

  7. Mortimer, E. A. (1994) Pertussis vaccine, in Vaccines, 2nd ed. (Plotkin, S. A. and Mortimer, E. A., eds.), Saunders, Philadelphia, pp. 91–136.

    Google Scholar 

  8. Hilleman, M. R. (1992) Vaccine perspectives from the vantage of hepatitis B. Vaccwe Res. 1, 1–15.

    CAS  Google Scholar 

  9. Egea, E, Iglesias, A, Salazar, M, Morimoto, C., Kruskall, M. S., Awdeh, Z., Schlossman, S. F, Alper, C. A, and Yunis, E. J. (1991) The cellular basis for lack of antibody response to hepatitis B vaccine in humans. J. Exp. Med. 173, 531–542

    Article  PubMed  CAS  Google Scholar 

  10. Langmuir, I. D., Bregman, D. J., Kurland, L. D., Nathanson, N., and Victor, M. (1984) An epidemiological and clinical evaluation of Guillain-Barre syndrome reported in association with the administration of swine influenza vaccine. J. Epidemiol. 119, 841–879.

    CAS  Google Scholar 

  11. Stratton, K. R., Howe, C. J., and Johnston, R. B. (1994) Adverse events associated with childhood vaccines. Evidence bearing on causality. Institute of Medicine, National Academy Press, Washington, pp. 1–464.

    Google Scholar 

  12. Galaska, A M., Lauer, B. A, Henderson, R. H., and Keja, J. (1984) Indications and contraindications for vaccines used in the expanded programme of immunization. Bull. WHO 62, 357–366.

    Google Scholar 

  13. Halsey, N. A. (1993) Increased mortality following high titer measles vaccines: too much of a good thing. Pedia. Infect. Dis. 12, 462–465.

    Article  CAS  Google Scholar 

  14. Kapikian, A. Z., Mitchell, R H., and Chanock, R. M. (1969) An epidemiological study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with inactivated RS virus vaccine. Am. J, Epidemiol. 89, 405–421.

    CAS  Google Scholar 

  15. Expanded Programme on Immunization. Certification of poliomyelitis eradicationthe Americas, 1944. (1994) Weekly Epidemiological Record 69, 293–295

    Google Scholar 

  16. Fenner, F. (1984) Viral vectors for vaccines, in New Approaches for Vaccine Development (Bell, R and Torrigiani, G, eds.), Schwabe, Basel, pp. 187–192.

    Google Scholar 

  17. WHO Consultative Group on Poliomyelitis Vaccines. (1984) Report to World Health Organization, Geneva.

    Google Scholar 

  18. Measles elimination by the year 2000! (1994) EPI Newsletter, Pan American Health Organization, Washington. 16, 1–2

    Google Scholar 

  19. Douglas, R. G. (1993) The children’s vaccine initiative-will it work? J Inj. Dis 168, 269–274.

    Google Scholar 

  20. Tam, J. P (1988) Synthetic peptide vaccine design: synthesis and properties of a high density multiple antigenic peptide system. Proc. Natl. Acad. Sci. USA 85, 5409–5413.

    Article  PubMed  CAS  Google Scholar 

  21. Pruksakorn, S., Currie, B., Brandt, E., Martin, D., Galbraith, A, Phornphutkul, C., Hunsakunachai, S., Manmontri, A., and Good, M. F (1994) Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci. Lancet 344, 639–642.

    Article  PubMed  CAS  Google Scholar 

  22. Kaumaya, P. T. P, Berndt, K. D., Herdorn, D. B., Trewhella, J., Kezdy, F. J., and Goldberg, E. (1990) Synthesis and biochemical characterization of engineered topographic immunogenic determinants with topology Biochemistry 29, 13–23

    Article  PubMed  CAS  Google Scholar 

  23. Ada, G. L. (1993) Vaccines, in Fundamental Immunology, 3rd ed. (Paul, W. E., ed.), Raven, New York, pp 1309–1352.

    Google Scholar 

  24. Ramsay, A. J., Husband, A. J., Ramshaw, I. A., Bao, S., Mattaei, K. I, Koehler, G., and Kopf, M. (1994) The role of interleukin-6 in mucosal IgA antibody responses in vivo Science 264, 561–563

    Article  PubMed  CAS  Google Scholar 

  25. Schodel, F., Aguado, M.-T., and Lambert, P.-H (1994) Introduction: nucleic acid vaccines. Plus other contributions. Vaccine 12, 1491–1550.

    Article  Google Scholar 

  26. Leung, K. N. and Ada, G. L (1982) Different functions of subsets of effector T-cells in murine influenza virus infection. Cell Immunol. 67, 312–324.

    Article  PubMed  CAS  Google Scholar 

  27. Larson, H. S., Russell, R. G., and Rouse, B. Y (1983) Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes Infect Immunol 41, 197–204.

    Google Scholar 

  28. Jackson, D. C., Ada, G. L., and Tha Lha, R. (1976) Cytotoxic T cells recoginze very early, minor changes in ectromelia virus-infected target cells. Aust J Exp Biol Med. Sci. 54, 349–363

    Article  PubMed  CAS  Google Scholar 

  29. Zinkernagel, R. M and Althage, A. (1977) Anti-viral protection by virus-immune cytotoxic T cells: infected targeT-cells are lysed before infectious virus progeny is assembled. J. Exp Med 145, 644–651

    Article  PubMed  CAS  Google Scholar 

  30. Geisow, M. J (1991) Unravelling the mysteries of molecular audit: MHC class I restriction. Tibtech 9, 403–404.

    CAS  Google Scholar 

  31. Ada, G. (1994) Twenty years into the saga of MHC-restriction. Immunol. Cell Blol. 72, 447–454.

    Article  CAS  Google Scholar 

  32. Taylor, G. (1994) The role of antibody in controlling and/or clearing virus infections, in Strategies in Vaccine Design (Ada, G. L, ed.), Landes, Austin, TX, pp. 17–34.

    Google Scholar 

  33. Griffin, D. E., Levine, B., Tyor, W. B., and Irani, D N. (1992) The immune response in viral encephalitis. Semin Immunol. 4, 111–119.

    PubMed  CAS  Google Scholar 

  34. Ramshaw, I., Ruby, J., Ramsay, A., Ada, G., and Karupiah, G. (1992) Expression of cytokines by recombinant vaccinia viruses: a model for studying cytokines in virus infections in vivo. Immunol. Rev. 127, 157–182.

    Article  PubMed  CAS  Google Scholar 

  35. Ada, G. L. (1990) The immune response to antigens: the immunological principles of vaccination. Lancet 335, 523–526

    Article  PubMed  CAS  Google Scholar 

  36. Sharma, D. P., Ramsay, A. J., and Ramshaw, I. A. (1995) Interleukin 4 expression enhances the pathogenicity of vaccinia virus and suppresses cytotoxic T lymphocyte responses. J. Exp. Med. submitted.

    Google Scholar 

  37. Afonso, L. C. C., Scharton, T. M., Vieira, L. Q., Wysocka, M, Trinchieri, G., and Scott, P(1994) The adJuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263, 235–237

    Article  PubMed  CAS  Google Scholar 

  38. Cooper, P. D. (1994) The selective induction of different immune responses by vaccine adjuvants, in Strategies in Vaccine Design (Ada, G. L., ed.), Landes, Austin, TX, pp. 129–158.

    Google Scholar 

  39. Ada, G. L. (1995) The development of new vaccines, in Vaccination and World Health (Cutts, F and Smith, P. G., eds.), Wiley, in press.

    Google Scholar 

  40. Gautam, A. M. and Glynn, P. (1990) Competition between foreign and self proteins in antigen presentation. Ovalbumin can inhibit activation of myelin basic protein-specific T-cells J.Immunol. 144, 1177–1180.

    PubMed  CAS  Google Scholar 

  41. Graham, B. S., Matthews, T. J., Belshe, R. B., Clements, M. L., Dolin, R., and Wright, P. F. (1993) Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp l60 recombinant vaccinia and boosting with rgp160 in vaccinia naive adults. J. Infect. Dis. 167, 533–537.

    PubMed  CAS  Google Scholar 

  42. El-Daher, N., Keefer, M. C, Reichman, R. C., Dolin, R., and Roberts, N. S. (1993) Persisting immunodefictiency virus type 1 gp160-specific human T lymphocyte responses including CD8+ cytotoxic activity after receipt of envelope vaccines. J Infect Dis. 168, 306–313

    PubMed  CAS  Google Scholar 

  43. Plotkin, S. A. and Mortimer, E. A. (eds.) (1994) Vaccines. W B. Saunders, Philadelphia.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra, Australia

    Gordon Ada

Authors
  1. Gordon Ada
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Centre for Applied Microbiology and Research, Porton Down, UK

    Andrew Robinson , Graham H. Farrar  & Christopher N. Wiblin ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Humana Press Inc, Totowa, NJ

About this protocol

Cite this protocol

Ada, G. (1996). Overview of Vaccines. In: Robinson, A., Farrar, G.H., Wiblin, C.N. (eds) Vaccine Protocols. Methods in Molecular Medicine™, vol 4. Humana Press. https://doi.org/10.1385/0-89603-334-1:1

Download citation

  • DOI: https://doi.org/10.1385/0-89603-334-1:1

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-334-4

  • Online ISBN: 978-1-59259-588-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation